Incyte Corporation: Premium Company Profile

Incyte is a development stage company involved in drug discovery and development activities with major focus on developing small molecule drugs to treat various diseases. The company has proprietary product pipeline in various stages of development for the treatment of oncology, inflammation, diabetes and HIV.

Report Highlights
Incyte operates in one segment, biotechnology drug discovery and development. The company’s proprietary pipeline programs in various stages of development include: Janus-associated Kinase 2 (JAK 2) program for inflammation, hematologic malignancies, and solid tumors; Incyte’s total revenues decreased at a CAGR of 27% from $95 million to $28 million during the historical period 2002-2006. The company derived revenues solely from royalties, license fee and collaboration. During 2006-2010, Incyte’s forecast revenues would decrease at a CAGR of 5% from $28 million to $23 million, likely due to the diminishing market for information products.
[Studien Infos ausblenden]

Overview 1
Catalyst 1
Summary 1
Company Structure 6
Company Overview and Key Facts 6
Business Description 7
History 8
Locations and Subsidiaries 10
Company Financials 11
Stock Market Performance 11
P&L 13
Balance Sheet 16
Cash Flow 16
Products & Services 17
Pipeline Products 17
AC Forecast Product Sales 19
Competitors and Strategic Business Relationships 20
Key Competitors 20
Key Clients 20
Shareholding Structure 21
Strategy 22
Company View 22
Corporate Strategy 24
SWOT Analysis 26
Overview 26
Strengths 27
Weaknesses 28
Opportunities 29
Threats 31
Value Chain Analysis 32
Overview 32
Discovery and Product Development 32
Scorecard 33
Overview 33
Scorecard Analysis 34
Key Employees 35
List of Employees 35
Key Employee Biographies 36
Financial and Operational Overview 43
Financial and Operational Overview 43
APPENDIX 45
Ask the analyst 45
Datamonitor consulting 45
Disclaimer 45
[Inhaltsverzeichnis ausblenden]

Table 1: Incyte - Key Facts 6
Table 2: Incyte – Locations and Subsidiaries 10
Table 3: Incyte - Year-End Share Price and Market Capitalization, 2002-2006 ($) 11
Table 4: Incyte - Key Events Impacting Share Price Performance 12
Table 5: Incyte - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 13
Table 6: Incyte - Operating Cost Ratio Analysis, 2002-2006 (% of total revenues) 15
Table 7: Incyte - Balance Sheet 16
Table 8: Incyte - Cash Flow 16
Table 9: Incyte - In-house Pipeline Products 17
Table 10: Incyte - Forecast Sales, 2006-2010 ($ Mn) 19
Table 11: Incyte - Key Competitors 20
Table 12: Incyte - Key Clients 20
Table 13: Incyte - Key Shareholders 21
Table 14: Incyte - SWOT Analysis Summary 26
Table 15: Incyte - Value Chain Analysis 32
Table 16: Incyte - Scorecard 33
Table 17: Incyte - Key Employees 35
Table 18: Incyte - Financial and Operational Overview 43
Figure 1: Incyte - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 14
[Tabellenverzeichnis ausblenden]